These data confirmed that the observed aggressive nature of prostate tumors harboring Pten Zfp36 loss was in part due to a significant increase in tumor cell NF-κB activity and a resulting overall inflammatory phenotype. This evidence concerns the gene PTEN and prostate neoplasm.